Stroke/Cerebrovascular Disease News

• SGLT-2 inhibitors as First-Line Therapy in Type 2 Diabetes? Real-world study finds heart failure hospitalization reduction compared to metformin but not MI, stroke, or overall mortality, and greater genital infection risk.
  Medscape Medical News, May 23, 2022
• Fewer Teens Giving Birth, but Cases Are More Complex Rates of obesity, mental health conditions, diabetes, and delivery complications have increased among teens giving birth.
  Medscape Medical News, May 23, 2022
• Hearing, Vision Loss Combo a Colossal Risk for Cognitive Decline Seniors with hearing or vision loss are at significant risk of cognitive decline, but the risk skyrockets in individuals with both.
  Medscape Medical News, May 23, 2022
• ESOC 2022 Thrombolysis Safe in Stroke Patients on Oral Anticoagulants A new observational study finds IV thrombolysis for acute stroke is safe for patients receiving direct oral anticoagulant therapy, prompting researchers to ask if current guidelines should be changed.
  Medscape Medical News, May 23, 2022
• SCAI 2022 SCAI Issues Guidelines for PFO Management, Makes Case for Expansion Clinical guidelines address expanded indications for percutaneous patent foramen ovale closure along with antiplatelet and anticoagulation therapy.
  Medscape Medical News, May 20, 2022
• Genomic Risk Score Predicts Intracerebral Hemorrhage Risk A metagenomic risk score combined with clinical risk factors shows promise.
  First Look, May 19, 2022
• EuroPCR 2022 JenaValve Trilogy Takes Another Step Forward in Severe AR The TAVI system met both the primary safety and efficacy endpoints in the first real-world study since its recent approval in Europe. A pivotal trial in ongoing in the United States.
  Medscape Medical News, May 19, 2022
• EuroPCR 2022 One-Month DAPT Enough for Complex PCI if Bleeding Risk High Latest data from the MASTER DAPT trial show similar results in the subgroup of patients who underwent complex PCI as in the main trial.
  Medscape Medical News, May 18, 2022
• ESOC 2022 High IL-6 Levels Linked to Carotid Plaque Severity, Progression Increased circulating levels of interleukin 6 are linked to increased carotid plaque severity and progression, say researchers who also identified a way to select patients for anti-IL-6 therapy.
  Medscape Medical News, May 18, 2022
• Updated AHA/ASA Guideline Changes Care for Spontaneous ICH Several "standard care" therapies for ICH are not as effective as once thought and are no longer recommended in updated guidelines.
  Medscape Medical News, May 17, 2022
• ESOC 2022 Stroke in the Young: Cancer in Disguise? Young stroke patients have an increased risk of being diagnosed with a new cancer in the years following their stroke, a new study shows.
  Medscape Medical News, May 13, 2022
• ESOC 2022 Recurrent Stroke Risk High in AF, Even With Anticoagulants A new study has found dangerously high levels of stroke recurrence and death among patients who take DOAC or VKA therapy, which researchers say demonstrates an unmet medical need.
  Medscape Medical News, May 13, 2022
• DDW 2022 NAFLD in Lean Patients Linked to CVD Risk The link between nonalcoholic fatty liver disease and higher risk of cardiovascular disease may extend beyond people who are overweight or living with obesity.
  Medscape Medical News, May 13, 2022
• ESOC 2022 Uncertain Results for Tenecteplase in 'Wake-up' Stroke The TWIST trial aimed to show benefit of the new bolus thrombolytic in patients with 'wake-up' stroke selected by noncontrast CT, but turned out to be underpowered to achieve a definitive result.
  Medscape Medical News, May 12, 2022
• Life Expectancy Important When Deciding on Intensive BP Lowering Starting intensive antihypertensive therapy may be most appropriate for adults expected to live at least three more years. For those with a life expectancy of less than one year, the harms of intensive BP control may outweigh the benefits.
  Reuters Health Information, May 10, 2022
• ESOC 2022 Exenatide Linked to Less Hyperglycemia After Stroke The diabetes drug may offer better control than insulin for hyperglycemia, a common condition following stroke that leads to worse outcomes.
  Medscape Medical News, May 11, 2022
• ESOC 2022 Taking ICH Cases Straight to Endovascular Center May Cause Harm RACECAT trial results suggest the longer travel times to the comprehensive stroke center -- rather than going to a closer primary stroke center -- could be harmful for patients having a hemorrhagic stroke.
  Medscape Medical News, May 11, 2022
• Espresso Coffee Associated With Increased Total Cholesterol New observational data show that drinking espresso coffee is linked to higher total cholesterol levels, particularly in men. Boiled or plunger coffee was tied to higher cholesterol in both men and women.
  Medscape Medical News, May 11, 2022
• ESOC 2022 Second Trial Shows Thrombectomy Benefit in Basilar Artery Stroke The BAOCHE trial has shown a large benefit of endovascular thrombectomy for patients with a stroke caused by a basilar artery occlusion.
  Medscape Medical News, May 11, 2022
• Medical Education Programs Tell How Climate Change Affects Health Medical schools are educating the next generation of doctors on one of the most widespread, insidious health threats of our time.
  Medscape Medical News, May 10, 2022